287 related articles for article (PubMed ID: 29262503)
41. [Effect of salidroside on apoptosis of bone marrow mesenchymal stem cells induced by ara-C].
Wei YP; Bai H; Sun YQ; Bao S; Xi R; Liu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1572-7. PubMed ID: 24370051
[TBL] [Abstract][Full Text] [Related]
42. [Mechanism of miR-155 Promoting Drug Resistance in Childhood Acute Lymphoblastic Leukemia by Regulating Wnt/β-Catenin Signaling Pathway].
Huang HM; Wei YJ; Wang D; Wen XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):418-424. PubMed ID: 35395973
[TBL] [Abstract][Full Text] [Related]
43. Chemotherapy induces bcl-2 cleavage in lymphoid leukemic cell lines.
Fortney JE; Hall BM; Bartrug L; Gibson LF
Leuk Lymphoma; 2002 Nov; 43(11):2171-8. PubMed ID: 12533044
[TBL] [Abstract][Full Text] [Related]
44. BCL-2 expression in childhood leukemia versus spontaneous apoptosis, drug induced apoptosis, and in vitro drug resistance.
Haarman EG; Kaspers GJ; Pieters R; van Zantwijk CH; Broekema GJ; Hählen K; Veerman AJ
Adv Exp Med Biol; 1999; 457():325-33. PubMed ID: 10500808
[TBL] [Abstract][Full Text] [Related]
45. Down-regulation of CD19 expression inhibits proliferation, adhesion, migration and invasion and promotes apoptosis and the efficacy of chemotherapeutic agents and imatinib in SUP-B15 cells.
Wu J; Liang B; Qian Y; Tang L; Xing C; Zhuang Q; Shen Z; Jiang S; Yu K; Feng J
Cell Biol Int; 2018 Sep; 42(9):1228-1239. PubMed ID: 29809305
[TBL] [Abstract][Full Text] [Related]
46. Ribozyme-mediated inhibition of a Philadelphia chromosome-positive acute lymphoblastic leukemia cell line expressing the p190 bcr-abl oncogene.
Snyder DS; Wu Y; McMahon R; Yu L; Rossi JJ; Forman SJ
Biol Blood Marrow Transplant; 1997 Oct; 3(4):179-86. PubMed ID: 9360779
[TBL] [Abstract][Full Text] [Related]
47. [Anti-apoptotic effects of mesenchymal stem cells on cardiac myocytes: in vitro study with rats].
Qu H; Guo YH; Zhu XJ; Gao W; Mao JM
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):271-4. PubMed ID: 17425878
[TBL] [Abstract][Full Text] [Related]
48. [A novel bcl-2 antisense oligodeoxynucleotide F951 increases sensitivity of HL-60 cells to Ara-C].
Li DL; Lu LH; Chen YY; Lin ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):752-6. PubMed ID: 15631654
[TBL] [Abstract][Full Text] [Related]
49. Quantitation of resistance to cytosine arabinoside by myeloid leukemic cells expressing bcl-2.
Guedez L; Suresh A; Tung F; Zucali J
Eur J Haematol; 1996 Aug; 57(2):149-56. PubMed ID: 8856092
[TBL] [Abstract][Full Text] [Related]
50. [Relationship between the expression of the genes encoding the key enzymes for cytarabine metabolism and the pharmacokinetics of cytarabine in the treatment of childhood acute leukemia with high-dose cytarabine].
Xie XT; Jiang SY; Li BS; Yang LL
Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):276-80. PubMed ID: 19099730
[TBL] [Abstract][Full Text] [Related]
51. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358
[TBL] [Abstract][Full Text] [Related]
52. Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression.
Huang M; Inukai T; Miyake K; Tanaka Y; Kagami K; Abe M; Goto H; Minegishi M; Iwamoto S; Sugihara E; Watanabe A; Somazu S; Shinohara T; Oshiro H; Akahane K; Goi K; Sugita K
Cancer Med; 2018 Apr; 7(4):1297-1316. PubMed ID: 29473342
[TBL] [Abstract][Full Text] [Related]
53. BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia.
Jiang N; Koh GS; Lim JY; Kham SK; Ariffin H; Chew FT; Yeoh AE
Exp Hematol; 2011 Mar; 39(3):321-9, 329.e1-3. PubMed ID: 21130142
[TBL] [Abstract][Full Text] [Related]
54. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
Iwasa M; Miura Y; Fujishiro A; Fujii S; Sugino N; Yoshioka S; Yokota A; Hishita T; Hirai H; Andoh A; Ichinohe T; Maekawa T
Int J Hematol; 2017 May; 105(5):587-597. PubMed ID: 28044259
[TBL] [Abstract][Full Text] [Related]
55. Breast cancer cells release factors that induced apoptosis in human bone marrow stromal cells.
Fromigué O; Kheddoumi N; Lomri A; Marie PJ; Body JJ
J Bone Miner Res; 2001 Sep; 16(9):1600-10. PubMed ID: 11547830
[TBL] [Abstract][Full Text] [Related]
56. Disruption of the Hippo pathway promotes the proliferation of childhood acute lymphoblastic leukemia cells, inhibits apoptosis and chemosensitivity.
Jiang H; Zhang RB; Peng J; Ren L; Wang HD
Expert Rev Hematol; 2024 Jun; 17(6):269-274. PubMed ID: 38753450
[TBL] [Abstract][Full Text] [Related]
57. Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy.
Mudry RE; Fortney JE; York T; Hall BM; Gibson LF
Blood; 2000 Sep; 96(5):1926-32. PubMed ID: 10961896
[TBL] [Abstract][Full Text] [Related]
58. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
[TBL] [Abstract][Full Text] [Related]
59. Generation of reactive oxygen intermediates after treatment of blasts of acute myeloblastic leukemia with cytosine arabinoside: role of bcl-2.
Hedley DW; McCulloch EA
Leukemia; 1996 Jul; 10(7):1143-9. PubMed ID: 8683994
[TBL] [Abstract][Full Text] [Related]
60. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
Tesfai Y; Ford J; Carter KW; Firth MJ; O'Leary RA; Gottardo NG; Cole C; Kees UR
Leuk Res; 2012 Mar; 36(3):299-306. PubMed ID: 21889797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
